RE: IC - Undervalued healthcare opportunity28 Jul 2022 14:58
Thanks for sharing that, it's a positive article. Final paragraph from the pdf:
"Taking all the risk factors into account, and applying a small-cap liquidity discount, a fair
valuation of 70p a share is a reasonable 12-month target to value the equity at £131mn. If the
target price is achieved, Totally would be valued on enterprise valuation to Ebitda multiples of
13.7 (2022/3) and 10.5 (2023/24), and forward cash-adjusted PE ratios of 20.3 (2022/23) and
14. There is scope for earnings upgrades if the cash pile is used sensibly, too.
From a technical perspective, a close above April’s intraday high of 49.2p would be a major bull
chart signal to open up the possibility of a share price rally to the autumn 2017 high around
60p. Beyond that the January 2016 high of 83p is the next technical target. The catalyst for a
chart break-out above the April 2022 high could be the forthcoming trading update at the
annual meeting on 5 September 2022. Given the fundamentals supporting demand for Totally’s
services, the news is likely to be very positive and well received by the market. Buy."